Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
455.00
+13.55 (3.07%)
Last updated: Oct 1, 2025, 9:15 AM IST
Akums Drugs and Pharmaceuticals Employees
Akums Drugs and Pharmaceuticals had 7,536 employees as of March 31, 2025. The number of employees increased by 148 or 2.00% compared to the previous year.
Employees
7,536
Change (1Y)
148
Growth (1Y)
2.00%
Revenue / Employee
5.48M INR
Profits / Employee
453.13K INR
Market Cap
69.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7,536 | 148 | 2.00% |
Mar 31, 2024 | 7,388 | -7,612 | -50.75% |
Mar 31, 2023 | 15,000 | 477 | 3.28% |
Mar 31, 2022 | 14,523 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
Akums Drugs and Pharmaceuticals News
- 2 months ago - SIMMONS FIRST NATIONAL CORPORATION ANNOUNCES PRICING OF OFFERING OF COMMON STOCK - Benzinga
- 9 months ago - Akums Drugs and Pharmaceuticals shares fall over 6% following Income Tax Department search - Business Upturn
- 10 months ago - Akums Drugs secures Rs 1,760 deal to supply oral liquid formulations in Europe - Business Upturn
- 11 months ago - Akums Drugs partners with Jagdale to revolutionize India’s Ready-to-Drink nutritional beverage market - Business Upturn
- 11 months ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 11 months ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn
- 11 months ago - Akums Drugs and Pharmaceuticals shares fall 5% following weak Q2 earnings outlook - Business Upturn
- 11 months ago - Akums Drugs and Pharmaceuticals Q2 FY25 results: Revenue at ₹1,033.09 crore, down 12.5% YoY; profit at ₹66.65 crore, up 103.8% YoY - Business Upturn